Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse Dystrophin ELISA Kit (AC2956)
Cat.#: ASET-1545
Specifications
Description Mouse Dystrophin ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse Dystrophin concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.097 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 2-32 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1534 Human Apolipoprotein E ELISA Kit (AC2945) Quantitative inquiry ASET-2406 Hamster IL-6 ELISA Kit (AC3817) Quantitative inquiry ASET-2323 Human BLMH ELISA Kit (AC3734) Quantitative inquiry ASET-2388 Rabbit CRH ELISA Kit (AC3799) Quantitative inquiry ASET-2237 Human ATG3 ELISA Kit (AC3648) Quantitative inquiry ASET-1837 Mouse Nogo ELISA Kit (AC3248) Quantitative inquiry ASET-1236 Human AHSG ELISA Kit (AC2647) Quantitative inquiry ASET-1879 Mouse TIMP3 ELISA Kit (AC3290) Quantitative inquiry ASET-1827 Mouse CRF ELISA Kit (AC3238) Quantitative inquiry ASET-1948 Mouse IRS1 ELISA Kit (AC3359) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket